Biotech firm developing universal 'flu vaccine

A new vaccine that could offer lifetime protection against all types of ‘flu is being developed by UK biotech firm Acambis, it emerged today.

Biotech firm developing universal 'flu vaccine

A new vaccine that could offer lifetime protection against all types of ‘flu is being developed by UK biotech firm Acambis, it emerged today.

Cambridge-based Acambis said the vaccine would end the need for people to have ‘flu jabs each year and may also protect them against any virulent new strains that emerge.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited